News & Updates

Show Multimedia Only

Brivaracetam benefits Asian adults with uncontrolled focal-onset seizures

13 Sep 2024 by

Adjunctive brivaracetam (BRV) reduces seizure frequency and improves response in Asian adults with uncontrolled focal-onset seizures (FOS), findings from the phase III therapeutic confirmatory EP0083 study suggest.

Brivaracetam benefits Asian adults with uncontrolled focal-onset seizures

13 Sep 2024

Zasocitinib shows promise as psoriasis treatment

13 Sep 2024

In the treatment of psoriasis, selective inhibition of tyrosine kinase 2 (TYK2) with zasocitinib appears to have superior effects compared with placebo, with greater skin clearance observed over 12 weeks, according to data from a phase 2b study.

Zasocitinib shows promise as psoriasis treatment

13 Sep 2024

No link between COVID-19 vaccines and new-onset seizures

12 Sep 2024

Individuals who have been vaccinated against COVID-19 appear to have a risk of new-onset seizure that is similar to that observed among unvaccinated individuals, according to the results of a meta-analysis.

No link between COVID-19 vaccines and new-onset seizures

12 Sep 2024

Ovarian stimulation with individualized follitropin delta dosing boosts IVF success

12 Sep 2024 by

In women with elevated antimüllerian hormone (AMH) levels, tailoring follitropin delta doses based on AMH level and weight for ovarian stimulation helps improve live birth rates, according to the results of a meta-analysis.

Ovarian stimulation with individualized follitropin delta dosing boosts IVF success

12 Sep 2024

S1PRM safe, efficacious in severe UC

12 Sep 2024

Use of sphingosine 1-phosphate receptor modulators (S1PRM) demonstrates safety and efficacy in the treatment of moderate-to-severe ulcerative colitis (UC), results of a recent study have shown.

S1PRM safe, efficacious in severe UC

12 Sep 2024

Nirsevimab cuts risk of hospitalization for RSV-associated bronchiolitis

12 Sep 2024 by

The ENVIE* study demonstrates the real-world effectiveness of nirsevimab against hospitalization for bronchiolitis associated with respiratory syncytial virus (RSV) among infants <12 months of age in France.

Nirsevimab cuts risk of hospitalization for RSV-associated bronchiolitis

12 Sep 2024

Common antibiotics linked to serious skin reactions

11 Sep 2024 by

Several classes of commonly prescribed oral antibiotics appear to carry an increased risk of serious cutaneous adverse drug reactions (cADRs), according to a study.

Common antibiotics linked to serious skin reactions

11 Sep 2024

LNG-IUS use ups risk of depression

11 Sep 2024 by

Use of a levonorgestrel-releasing intrauterine system (LNG-IUS) appears to increase the risk of incident depression, defined as initiation of an antidepressant or receipt of a depression diagnosis, in a dose-dependent manner, suggests a study.

LNG-IUS use ups risk of depression

11 Sep 2024

Early diagnosis, antifungal therapy improve outcomes in invasive fungal sinusitis

11 Sep 2024

Children with invasive fungal sinusitis may benefit from early diagnosis, aggressive surgical intervention, and combined antifungal therapy to achieve better outcomes, suggests a study.

Early diagnosis, antifungal therapy improve outcomes in invasive fungal sinusitis

11 Sep 2024

Tenecteplase at 4.5–24 hours without thrombectomy feasible for ischaemic stroke

11 Sep 2024 by

The use of tenecteplase in the extended time window of 4.5–24 hours improves functional outcomes in patients with ischaemic stroke when endovascular thrombectomy (EVT) is not immediately available, findings from the phase III TRACE-III* trial suggest.

Tenecteplase at 4.5–24 hours without thrombectomy feasible for ischaemic stroke

11 Sep 2024

News & Updates

Filter by Specialty:

Specialty:

Brivaracetam benefits Asian adults with uncontrolled focal-onset seizures

Brivaracetam benefits Asian adults with uncontrolled focal-onset seizures

Zasocitinib shows promise as psoriasis treatment

Zasocitinib shows promise as psoriasis treatment

No link between COVID-19 vaccines and new-onset seizures

No link between COVID-19 vaccines and new-onset seizures

Ovarian stimulation with individualized follitropin delta dosing boosts IVF success

Ovarian stimulation with individualized follitropin delta dosing boosts IVF success

S1PRM safe, efficacious in severe UC

S1PRM safe, efficacious in severe UC

Nirsevimab cuts risk of hospitalization for RSV-associated bronchiolitis

Nirsevimab cuts risk of hospitalization for RSV-associated bronchiolitis

Common antibiotics linked to serious skin reactions

Common antibiotics linked to serious skin reactions

LNG-IUS use ups risk of depression

LNG-IUS use ups risk of depression

Early diagnosis, antifungal therapy improve outcomes in invasive fungal sinusitis

Early diagnosis, antifungal therapy improve outcomes in invasive fungal sinusitis

Tenecteplase at 4.5–24 hours without thrombectomy feasible for ischaemic stroke

Tenecteplase at 4.5–24 hours without thrombectomy feasible for ischaemic stroke